These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 18628967)

  • 41. MITF: master regulator of melanocyte development and melanoma oncogene.
    Levy C; Khaled M; Fisher DE
    Trends Mol Med; 2006 Sep; 12(9):406-14. PubMed ID: 16899407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
    Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
    Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
    Guo X; Xu Y; Zhao Z
    Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation.
    Phung B; Sun J; Schepsky A; Steingrimsson E; Rönnstrand L
    PLoS One; 2011; 6(8):e24064. PubMed ID: 21887372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation.
    Kumar SM; Dai J; Li S; Yang R; Yu H; Nathanson KL; Liu S; Zhou H; Guo J; Xu X
    Oncogene; 2014 Feb; 33(7):832-41. PubMed ID: 23334329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF.
    Choi J; Xu M; Makowski MM; Zhang T; Law MH; Kovacs MA; Granzhan A; Kim WJ; Parikh H; Gartside M; Trent JM; Teulade-Fichou MP; Iles MM; Newton-Bishop JA; Bishop DT; MacGregor S; Hayward NK; Vermeulen M; Brown KM
    Nat Genet; 2017 Sep; 49(9):1326-1335. PubMed ID: 28759004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.
    Flockhart RJ; Armstrong JL; Reynolds NJ; Lovat PE
    Br J Cancer; 2009 Oct; 101(8):1448-55. PubMed ID: 19724275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of microphthalmia transcription factor (Mitf) by forskolin and stimulation of melanin release in UISO-Mel-6 cells.
    Lekmine F; Salti GI
    J Surg Res; 2008 Sep; 149(1):27-30. PubMed ID: 18028952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma.
    Packer LM; East P; Reis-Filho JS; Marais R
    Pigment Cell Melanoma Res; 2009 Dec; 22(6):785-98. PubMed ID: 19682280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
    Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxia and MITF regulate KIT oncogenic properties in melanocytes.
    Laugier F; Delyon J; André J; Bensussan A; Dumaz N
    Oncogene; 2016 Sep; 35(38):5070-7. PubMed ID: 26973244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MITF suppression improves the sensitivity of melanoma cells to a BRAF inhibitor.
    Aida S; Sonobe Y; Tanimura H; Oikawa N; Yuhki M; Sakamoto H; Mizuno T
    Cancer Lett; 2017 Nov; 409():116-124. PubMed ID: 28923400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
    Schepsky A; Bruser K; Gunnarsson GJ; Goodall J; Hallsson JH; Goding CR; Steingrimsson E; Hecht A
    Mol Cell Biol; 2006 Dec; 26(23):8914-27. PubMed ID: 17000761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.
    Laurette P; Coassolo S; Davidson G; Michel I; Gambi G; Yao W; Sohier P; Li M; Mengus G; Larue L; Davidson I
    Cell Death Differ; 2020 Jan; 27(1):29-43. PubMed ID: 31065107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors.
    Azimi A; Caramuta S; Seashore-Ludlow B; Boström J; Robinson JL; Edfors F; Tuominen R; Kemper K; Krijgsman O; Peeper DS; Nielsen J; Hansson J; Egyhazi Brage S; Altun M; Uhlen M; Maddalo G
    Mol Syst Biol; 2018 Mar; 14(3):e7858. PubMed ID: 29507054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.
    Johannessen CM; Johnson LA; Piccioni F; Townes A; Frederick DT; Donahue MK; Narayan R; Flaherty KT; Wargo JA; Root DE; Garraway LA
    Nature; 2013 Dec; 504(7478):138-42. PubMed ID: 24185007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.
    McGill GG; Horstmann M; Widlund HR; Du J; Motyckova G; Nishimura EK; Lin YL; Ramaswamy S; Avery W; Ding HF; Jordan SA; Jackson IJ; Korsmeyer SJ; Golub TR; Fisher DE
    Cell; 2002 Jun; 109(6):707-18. PubMed ID: 12086670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MITF in melanoma: mechanisms behind its expression and activity.
    Hartman ML; Czyz M
    Cell Mol Life Sci; 2015 Apr; 72(7):1249-60. PubMed ID: 25433395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression.
    Carreira S; Goodall J; Aksan I; La Rocca SA; Galibert MD; Denat L; Larue L; Goding CR
    Nature; 2005 Feb; 433(7027):764-9. PubMed ID: 15716956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.